DYRK1A and leukemia: As a more general message, we can outline that DYRK1A is indeed a critical mediator of diverse processes in blood cell development and function, and its dysregulation certainly is a driver of pathologic states such as leukemia, autoinflammatory disorders and viral susceptibility, all of which are extremely relevant for individuals with Down syndrome.